Showing 1 - 20 results of 25 for search 'Jason Grebely', query time: 0.05s Refine Results
  1. 1
    Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia

    Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia by Mohammad T. Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study

    Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study by Anna Conway, Alison D. Marshall, Sione Crawford, Jeremy Hayllar, Jason Grebely, Carla Treloar

    Published 2023-06-01
    Get full text
    Article
  3. 3
    Sequencing of the Hepatitis C Virus: A Systematic Review.

    Sequencing of the Hepatitis C Virus: A Systematic Review. by Brendan Jacka, Francois Lamoury, Peter Simmonds, Gregory J Dore, Jason Grebely, Tanya Applegate

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications.

    Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications. by Jisoo A Kwon, Gregory J Dore, Behzad Hajarizadeh, Maryam Alavi, Heather Valerio, Jason Grebely, Rebecca Guy, Richard T Gray

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Hepatitis C in South Australia And Northern Territory: A Population-Based Linkage Study

    Hepatitis C in South Australia And Northern Territory: A Population-Based Linkage Study by Jacqueline H Stephens, Clare Bradley, Salenna Elliott, Gregory Dore, Jason Grebely, Maryam Alavi, Brendan Kennedy, Steven Tong, James Ward

    Published 2020-12-01
    Get full text
    Article
  6. 6
    Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000‐2014)

    Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000‐2014) by Reem Waziry, Jason Grebely, Janaki Amin, Maryam Alavi, Behzad Hajarizadeh, Jacob George, Gail V. Matthews, Matthew Law, Gregory J. Dore

    Published 2017-10-01
    Get full text
    Article
  7. 7
    Estimating the number of people who inject drugs in Australia

    Estimating the number of people who inject drugs in Australia by Sarah Larney, Matthew Hickman, Rebecca Guy, Jason Grebely, Gregory J. Dore, Richard T. Gray, Carolyn A. Day, Jo Kimber, Louisa Degenhardt

    Published 2017-09-01
    Get full text
    Article
  8. 8
    Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012

    Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012 by Maryam Alavi, Jason Grebely, Behzad Hajarizadeh, Janaki Amin, Sarah Larney, Matthew G. Law, Jacob George, Louisa Degenhardt, Gregory J. Dore

    Published 2018-05-01
    Get full text
    Article
  9. 9
    Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.

    Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort. by Joseph S Doyle, Jason Grebely, Tim Spelman, Maryam Alavi, Gail V Matthews, Alexander J Thompson, Gregory J Dore, Margaret E Hellard, ATAHC Study Group

    Published 2016-01-01
    Get full text
    Article
  10. 10
    Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs.

    Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. by Rachel Sacks-Davis, Galina Daraganova, Campbell Aitken, Peter Higgs, Lilly Tracy, Scott Bowden, Rebecca Jenkinson, David Rolls, Philippa Pattison, Garry Robins, Jason Grebely, Alyssa Barry, Margaret Hellard

    Published 2012-01-01
    Get full text
    Article
  11. 11
    Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012.

    Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012. by Jason Grebely, Viviane Dias Lima, Brandon D L Marshall, M-J Milloy, Kora DeBeck, Julio Montaner, Annick Simo, Mel Krajden, Gregory J Dore, Thomas Kerr, Evan Wood

    Published 2014-01-01
    Get full text
    Article
  12. 12
    Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection.

    Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection. by Jordan J Feld, Jason Grebely, Gail V Matthews, Tanya Applegate, Margaret Hellard, Alana Sherker, Vera Cherepanov, Kathy Petoumenos, Barbara Yeung, John M Kaldor, Andrew R Lloyd, Gregory J Dore

    Published 2013-01-01
    Get full text
    Article
  13. 13
    Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar

    Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar by Phyo Pyae Nyein, Shane Tillakeratne, Sabai Phyu, Myint Myint Yee, Mya Mya Lwin, Kyaw Linn Htike, May Thu Aung, Jason Grebely, Tanya Applegate, Josh Hanson, Gail Matthews, Kyaw Swar Lin

    Published 2023-02-01
    Get full text
    Article
  14. 14
    Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study

    Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study by Marianne Martinello, Sanjay Bhagani, David Shaw, Chloe Orkin, Graham Cooke, Edward Gane, David Iser, Andrew Ustianowski, Ranjababu Kulasegaram, Catherine Stedman, Elise Tu, Jason Grebely, Gregory J. Dore, Mark Nelson, Gail V. Matthews

    Published 2023-10-01
    Get full text
    Article
  15. 15
    SHARED: An International Collaboration to Unravel Hepatitis C Resistance

    SHARED: An International Collaboration to Unravel Hepatitis C Resistance by Anita Y.M. Howe, Francesca Ceccherini-Silberstein, Julia Dietz, Stephanie Popping, Jason Grebely, Chaturaka Rodrigo, Johan Lennerstrand, Mark W. Douglas, Milosz Parczewsk, P. Richard Harrigan, Jean-Michel Pawlotsky, Federico Garcia, SHARED Collaborators

    Published 2021-08-01
    Get full text
    Article
  16. 16
    Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study

    Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study by Anna Conway, Phillip Read, Rosie Gilliver, Tony McNaughton, Heather Valerio, Evan B. Cunningham, Charles Henderson, Brett Hadlow, Katrina Molloy, Anna Doab, Shane Tillakeratne, Lucy Pepolim, Mary Ellen Harrod, Gregory J. Dore, Jason Grebely

    Published 2022-11-01
    Get full text
    Article
  17. 17
    HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.

    HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection. by Sonya A MacParland, Saleh M Fadel, Vesna Mihajlovic, Ali Fawaz, Connie Kim, A K M Nur-Ur Rahman, Jun Liu, Rupert Kaul, Colin Kovacs, Jason Grebely, Gregory J Dore, David K Wong, Mario A Ostrowski

    Published 2016-01-01
    Get full text
    Article
  18. 18
    Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysisResearch in context

    Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysisResearch in context by Anna Levinsson, Camille Zolopa, Farzaneh Vakili, Sasha Udhesister, Nadine Kronfli, Mathieu Maheu-Giroux, Julie Bruneau, Heather Valerio, Sahar Bajis, Phillip Read, Elisa Martró, Lisa Boucher, Leith Morris, Jason Grebely, Adelina Artenie, Jack Stone, Peter Vickerman, Sarah Larney

    Published 2024-06-01
    Get full text
    Article
  19. 19
    The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)

    The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC) by Naveed Z. Janjua, DrPH, Margot Kuo, MPH, Amanda Yu, MSc, Maria Alvarez, MSc, Stanley Wong, MSc, Darrel Cook, MSc, Jason Wong, MD, Jason Grebely, PhD, Zahid A. Butt, PhD, Hasina Samji, PhD, Alnoor Ramji, MD, Mark Tyndall, MD, Mel Krajden, MD

    Published 2016-10-01
    Get full text
    Article
  20. 20
    Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot

    Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot by Nigel Carrington, Anna Conway, Jason Grebely, Mitchell Starr, Beth Catlett, Annabelle Stevens, Bianca Prain, Colette McGrath, Louise Causer, Rebecca Guy, Joanne Holden, Phillip Keen, Melanie Kingsland, Heng Lu, Cherie Power, Phillip Read, Carolyn Murray, Anna McNulty, Philip Cunningham, on behalf of the NSW DBS Pilot Study Group

    Published 2024-01-01
    Get full text
    Article

Search Tools: